These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1544847

  • 1. Mechanism of oncogenicity for bioreductive drugs.
    Hei TK, Piao CQ, He ZY, Hall EJ.
    Int J Radiat Oncol Biol Phys; 1992; 22(4):747-50. PubMed ID: 1544847
    [Abstract] [Full Text] [Related]

  • 2. Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential.
    Hei TK, He ZY, Piao CQ, Hall EJ.
    Radiat Res; 1990 Oct; 124(1 Suppl):S44-9. PubMed ID: 2236509
    [Abstract] [Full Text] [Related]

  • 3. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
    Roizin-Towle L, Pirro JP, Hall EJ.
    Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
    [Abstract] [Full Text] [Related]

  • 4. Oncogenic transforming potential of nitroimidazole radiosensitizers.
    Hall EJ, Hei TK.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
    [Abstract] [Full Text] [Related]

  • 5. Oncogenic potential of bifunctional bioreductive drugs.
    Hei TK, Liu SX, Hall EJ.
    Br J Cancer Suppl; 1996 Jul; 27():S57-60. PubMed ID: 8763847
    [Abstract] [Full Text] [Related]

  • 6. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC.
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.
    Lee AE, Wilson WR.
    Toxicol Appl Pharmacol; 2000 Feb 15; 163(1):50-9. PubMed ID: 10662604
    [Abstract] [Full Text] [Related]

  • 8. The experimental development of bioreductive drugs and their role in cancer therapy.
    Workman P, Stratford IJ.
    Cancer Metastasis Rev; 1993 Jun 15; 12(2):73-82. PubMed ID: 8375022
    [Abstract] [Full Text] [Related]

  • 9. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
    Hei TK, Geard CR, Osmak RS, Hall EJ.
    Int J Radiat Oncol Biol Phys; 1985 Sep 15; 11(9):1653-8. PubMed ID: 3839777
    [Abstract] [Full Text] [Related]

  • 10. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
    Olive PL.
    Acta Oncol; 1995 Sep 15; 34(3):301-5. PubMed ID: 7779413
    [Abstract] [Full Text] [Related]

  • 11. Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
    McAleer JJ, McKeown SR, MacManus MP, Lappin TR, Bridges JM.
    Int J Radiat Oncol Biol Phys; 1992 Sep 15; 23(3):551-5. PubMed ID: 1612955
    [Abstract] [Full Text] [Related]

  • 12. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    Keohane A, Godden J, Stratford IJ, Adams GE.
    Br J Cancer; 1990 May 15; 61(5):722-6. PubMed ID: 2110815
    [Abstract] [Full Text] [Related]

  • 13. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
    Stratford IJ, Walling JM, Silver AR.
    Br J Cancer; 1986 Mar 15; 53(3):339-44. PubMed ID: 3754453
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
    Binger M, Workman P.
    Cancer Chemother Pharmacol; 1991 Mar 15; 29(1):37-47. PubMed ID: 1742848
    [Abstract] [Full Text] [Related]

  • 15. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
    Adams GE, Stratford IJ, Edwards HS, Bremner JC, Cole S.
    Int J Radiat Oncol Biol Phys; 1992 Mar 15; 22(4):717-20. PubMed ID: 1544844
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxicity of dual function nitrofurans in rodent and human tumor cells.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1992 Mar 15; 22(4):697-700. PubMed ID: 1544840
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
    Siemann DW, Sutherland RM.
    Radiother Oncol; 1992 Aug 15; 24(4):239-45. PubMed ID: 1410579
    [Abstract] [Full Text] [Related]

  • 18. Bioreductive therapies: an overview of drugs and their mechanisms of action.
    Rauth AM, Melo T, Misra V.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):755-62. PubMed ID: 9845091
    [Abstract] [Full Text] [Related]

  • 19. Photosensitive interaction of RSU 1069 with DNA.
    Edwards DI, Knox RJ, Skolimowski IM, Zahoor A, Knight RC.
    Int J Radiat Oncol Biol Phys; 1984 Aug 01; 10(8):1319-22. PubMed ID: 6547937
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of bioreductive drugs in multicell spheroids.
    Durand RE, Olive PL.
    Int J Radiat Oncol Biol Phys; 1992 Aug 01; 22(4):689-92. PubMed ID: 1544838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.